Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE studyDarryl C. De Vivo, Wildon Farwell, Enrico Bertini et al.|Neuromuscular Disorders|2019Cited by 636
225P Initial data from the DELIVER trial of DYNE-251 in males with DMD Mutations amenable to Exon 51 skippingL. De Waele, M. Guglieri, M. Lorentzos et al.|Neuromuscular Disorders|2024Cited by 1